Curis Inc. (CRIS) Soars 5.13% on February 01

Curis Inc. (CRIS) Soars 5.13% on February 01

Curis Inc. (CRIS) had a good day on the market for Friday February 01 as shares jumped 5.13% to close at $1.23. About 168,577 shares traded hands on 615 trades for the day, compared with an average daily volume of n/a shares out of a total float of 33.11 million. After opening the trading day at $1.18, shares of Curis Inc. stayed within a range of $1.24 to $1.15.

With today’s gains, Curis Inc. now has a market cap of $40.73 million. Shares of Curis Inc. have been trading within a range of $5.20 and $0.60 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include CUDC-907, CA-170, CA-4948, CA-327, and Erivedge.

Curis Inc. is based out of Lexington, MA and has some 55 employees. Its CEO is James E. Dentzer.

Share:
Scroll Up
error: Content is protected !!